Dow Down 0.74% Nasdaq Down 0.70%

Aegerion Pharmaceuticals, Inc. (AEGR)

-NMS
32.86 Down 0.52(1.56%) 11:09AM EDT - Nasdaq Real Time Price
Prev Close:33.38
Open:33.27
Bid:32.53 x 200
Ask:32.58 x 200
1y Target Est:66.10
Beta:0.46
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:32.17 - 33.78
52wk Range:26.25 - 101.00
Volume:257,582
Avg Vol (3m):1,069,530
Market Cap:970.91M
P/E (ttm):N/A
EPS (ttm):-1.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AEGR

Comparison

Symbol% ChgMkt Cap
AEGRDown 1.56%970.91M
AZNDown 1.01%89.32B
MRKDown 0.25%170.57B
PFEDown 0.85%185.91B

Key Statistics

Forward P/E (1 yr):15.95
P/S (ttm):9.50
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.86
Quarterly EPS Est (Sep-14) :-0.13
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback